版本:
中国

BRIEF-Arca Biopharma announces 200th patient randomized into the genetic-AF phase 2b/3 clinical trial

April 26 Arca Biopharma Inc

* Arca Biopharma announces 200th patient randomized into the genetic-AF seamless design phase 2b/3 clinical trial

* Outcome of phase 2B interim efficacy analysis anticipated in September 2017 Source text for Eikon: Further company coverage:

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐